Related Experiment Video
Updated: Apr 18, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Hepatitis B virus infection in patients with blood disorders: a concise review in pediatric study
Insights
Childhood Hepatitis B virus (HBV) infection poses significant health risks, with infants facing a high chance of chronic infection. This study highlights the link between viral infections like HBV and HCV and various cancers, particularly leukemia.
Area of Science:
- Hepatology
- Oncology
- Infectious Diseases
Background:
- Childhood Hepatitis B virus (HBV) infection presents substantial medical and public health challenges.
- Infants infected perinatally have a high risk (up to 90%) of developing chronic HBV infection.
- Viral infections contribute to approximately 10% of global cancers, predominantly in developing nations.
Purpose of the Study:
- To investigate the prevalence of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) markers in patients with malignancies.
- To explore the association between hepatitis viral infections and leukemia.
Main Methods:
- A comprehensive web-based literature review was conducted.
- Searched databases included Iran Medex, MEDLINE/PubMed, and CINAHL.
- Included Persian and English peer-reviewed articles on HBV, HCV, and blood disorders in malignancies.
Main Results:
- A high prevalence of HBV and HCV infective markers was observed in patients with various malignancies.
- Elevated rates of HBV markers were noted in cancer patients compared to the general population.
- A significant prevalence of HBV markers in leukemia patients suggests a strong association with hepatitis viral infections.
Conclusions:
- Hepatitis B and C viral infections are prevalent in patients with malignancies.
- There is a strong association between hepatitis viral infections and leukemia.
- Further research is warranted to elucidate the mechanisms underlying these associations.
Abstract:
Childhood Hepatitis B virus (HBV) infection causes both medical and public health challenges. Infants who acquire HBV parentally have up to 90% risk of developing chronic HBV infection. It is now estimated that approximately 10% of worldwide cancers are attributable to viral infection, with the vast majority (>85 %) occurring in the developing world. In this distribution, elevated rate and prevalence of HBV marker have been found in patients with malignancies as compared to the general population. By reviewing the web-based search for all Persian and English types of scientific peer review published articles initiated using Iran Medex, MEDLINE/PubMed, CINAHL and other pertinent references on websites about HBV and HCV blood disorders. The high prevalence of HBV and HCV infective markers was detected in patients with different malignancies. Moreover, identification of high prevalence of HBV infective markers in leukemia patients proposed strong association between hepatitis viral infections and leukemia.
Related Concept Videos
Hepatitis
Pharmacokinetics in Pediatric Patients: Drug Excretion
Viral Hepatitis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

